Peptides based on the sequence of human lactoferrin and their use
CA 2333306 C · Owner: Pharmasurgics In Sweden Ab · Inventors: Hanson, Lars A.; Mattsby-Baltzer, Inger; Baltzer, Lars
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40 counted from the N-terminal , end, in the sequence constituting human lactoferrin and preferably , modifications thereof. The invention also relates to medicinal products comprising such peptides, especially intended for treatment and prevention of infections, inflammations and tumours. Furthermore the invention relates to , food stuff, e.g. infant formula food comprising the above mentioned peptides.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 6, 1999 and granted December 6, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 6, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 6, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.